TWO: The New York Times stated the result of a broad study, which showed that up to 90 percent of all COVID cases, based on a positive PCR test, were false positives. Non-cases.
Combining these two developments, the implication is quite clear: we’re in the middle of a less-than-average “flu season.”
by Jon Rappoport
The news media are accusing Trump of trying to rush a COVID vaccine into use by November 1, just before the election: “The president is playing politics.”
Suddenly, the press is expressing “deep concern” about the safety and efficacy of the vaccine. Experts are being trotted out to issue warnings.
The White House is saying they would never compromise the safety of the public.
The FDA is strenuously insisting their decision to authorize a COVID vaccine will be undertaken with extreme care, and will not bow to pressure.
Of course, if Obama or Hillary were in the White House now, the press would be praising them for their efforts to move “full speed ahead.”
If Trump were now talking about a need to delay the vaccine, in order to “get it right,” the press would be screaming about the necessity of approving a vaccine quickly “to save lives.”
As I’ve been writing, the media definition of science is now “the opposite of whatever Trump says.”
The White House definition is whatever the White House says.
The public is caught in the middle.
There are three leading corporate competitors vying for an upcoming COVID vaccine. One of them is Moderna. This is a small US company that has never brought a product of any kind to market. In other words, their credibility is zero. Yet they’ve garnered half a billion dollars of federal money for research. The press isn’t screaming about that.
Fauci likes Moderna. Bill Gates likes Moderna.
MCViewPoint 